Indicated for: chronic hepatitis C
Substance: telaprevir (antiviral)
ATC: J05AE11 (Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors)
Telaprevir is an NS3/4A protease inhibitor used for the treatment of chronic hepatitis C, particularly in patients with genotype 1 of the virus. It works by blocking the activity of the viral protease, which is essential for hepatitis C virus replication.
The medication is taken orally, usually three times daily, in combination with other antiviral medications, as directed by a doctor. It is important for patients to follow the prescribed dosage and complete the full course of treatment to prevent recurrence of the infection.
Patients should be aware of potential side effects, such as skin rashes, anemia, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include skin rashes, nausea, fatigue, and anemia. In rare cases, severe reactions such as serious allergic reactions or liver failure may occur. Patients should be informed of these risks before starting treatment.